Experimental treatments for acute ischaemic stroke (Q36720333)

15 August 2017

1 reference

title

Experimental treatments for acute ischaemic stroke (English)

1 reference

15 August 2017

1

Ralph L Sacco

1 reference

15 August 2017

4

Mitchell S V Elkind

1 reference

15 August 2017

Ji Y Chong

2

1 reference

15 August 2017

Shyam Prabhakaran

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

369

1 reference

15 August 2017

issue

9558

1 reference

15 August 2017

page(s)

331-341

1 reference

Quality improvement in acute stroke: the New York State Stroke Center Designation Project

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Argatroban tPA stroke study: study design and results in the first treated cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Imaging-guided extension of the time window: ready for application in experienced stroke centers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Refining the Perfusion–Diffusion Mismatch Hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Microbubbles and ultrasound: from diagnosis to therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

New and future endovascular treatment strategies for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Snare retrieval of intracranial thrombus in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Rescue angioplasty after failed intra-arterial thrombolysis in acute middle cerebral artery stroke: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Blood pressure and clinical outcomes in the International Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

A pilot study of drug-induced hypertension for treatment of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

1,026 experimental treatments in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

NXY-059 for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Pilot Dose-Escalation Study of Caffeine Plus Ethanol (Caffeinol) in Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the Heart Protection Study on standards of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Recommendations for clinical trial evaluation of acute stroke therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Enhancing the Development and Approval of Acute Stroke Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960155-X

7 January 2021

10.1016/S0140-6736(07)60155-X

Identifiers

DOI

1 reference

15 August 2017

1 reference